Moderna Inc: News
15 Sep 2021
ResearchModerna COVID-19 vaccine produces lasting immune response: Study
Immunity generated by the Moderna COVID-19 vaccine lasts for at least six months, and there is no indicator that vaccinated people will need a booster shot, according to a study.
26 Aug 2021
JapanJapan suspends 1.63mn Moderna vaccine doses after contamination found
Japan suspended use of about 1.63 million Moderna vaccine doses on Thursday after contamination was found in unused vials, raising concern of a supply shortage as the country tries to accelerate vaccinations amid a COVID-19 surge.
20 Jul 2021
PfizerNo sign of Pfizer, Moderna vaccines in breast milk: Study
Researchers have found no evidence of the presence of Pfizer or Moderna COVID-19 vaccines in breast milk suggesting that mRNA preventives are safe during lactation.
20 Jul 2021
Drugs Controller General of IndiaIndia offered 7.5mn doses of Moderna vaccine under COVAX program
India has been offered 7.5 million doses of Moderna's COVID-19 vaccine through the COVAX global vaccine sharing program, but it is not clear when the jabs will arrive in the country as a consensus on the indemnity clause is yet to be reached, sources said.
04 Jul 2021
VaccineModerna vaccine arriving in India in 2-3 days: Report
Moderna's COVID-19 vaccine is reportedly expected to reach India in the next few days.
29 Jun 2021
VaccineCipla gets DCGI nod to import Moderna COVID-19 vaccine
The Drugs Controller General of India (DCGI) has reportedly allowed the pharmaceutical firm Cipla to import the COVID-19 vaccine developed by US-based biotechnology company Moderna Inc.
16 Jun 2021
SARS-CoV-2Two COVID-19 vaccines for young children show promise in trials
The Moderna COVID-19 vaccine and an experimental protein-based preventive proved to be safe and showed good antibody response against SARS-CoV-2 in a trial on baby rhesus macaques, scientists said.
03 Jun 2021
PfizerMost COVID-19 vaccines might offer lasting protection: Study
The world's leading COVID-19 vaccines, including the ones from Pfizer and Moderna, may offer lasting protection that diminishes the need for frequent booster shots.
02 Jun 2021
PfizerForeign COVID-19 vaccines exempted from local trials, batch testing
The Drugs Controller General of India has scrapped the requirement of local trials for foreign-made coronavirus vaccines - a key move to upscale the dwindling COVID-19 vaccinations in the country.
27 May 2021
PfizerPfizer's vaccine works against B.1.617 variant, firm tells Indian government
Pfizer has told the Indian government that its coronavirus vaccine shows "high effectiveness" on the COVID-19 variant prevalent in India as well as on people of Indian ethnicity or nationality.
25 May 2021
PfizerIndia may not receive Pfizer, Moderna vaccine doses until 2023
India may not receive doses of the COVID-19 vaccines developed by Pfizer and Moderna until 2023 as the manufacturers have other commitments.
24 May 2021
Arvind KejriwalPfizer, Moderna have refused to sell vaccines directly to Delhi
American pharmaceutical companies Pfizer and Moderna have said they would not sell their coronavirus vaccines directly to the Delhi government, Chief Minister Arvind Kejriwal revealed today.
14 May 2021
PfizerAmericans can finally ditch the mask, says CDC
In the biggest indication that the United States is fast returning to pre-pandemic life, the Centers for Disease Control and Prevention (CDC) has said fully vaccinated people are no longer required to wear masks.
13 May 2021
MaharashtraNawab Malik questions French embassy's procurement of Moderna vaccine
Maharashtra minister Nawab Malik on Thursday claimed that India's French embassy has procured Moderna anti-coronavirus vaccine and it is being administered to its nationals at Navi Mumbai even as only three other vaccines are permitted in India.
30 Mar 2021
PfizerPfizer, Moderna's coronavirus vaccines effective even after first dose: Study
The coronavirus vaccines developed by American pharma giant Pfizer, with Germany's BioNTech, and the one manufactured by Moderna, another United States company, reduce the risk of infection even after the first dose, a study has found, reports Reuters.
01 Mar 2021
CoronavirusAstraZeneca has sold its stake in Moderna for $1 billion
British pharmaceutical company AstraZeneca Plc has sold its 7.7 percent stake in Moderna Inc., the American pharmaceutical giant, for more than $1 billion, according to a report in The Times.
04 Feb 2021
PfizerRecovered COVID-19 patients need only one shot of mRNA vaccines
People who have recovered from COVID-19 may need only one shot as opposed to the recommended two jabs if they are taking the Moderna or Pfizer vaccines, according to a study that suggests ways to minimize doses when supplies are limited.
27 Jan 2021
PfizerUS to purchase additional 200 million coronavirus vaccine doses
US President Joe Biden on Tuesday announced the purchase of additional 200 million doses of coronavirus vaccines as the country reached 25 million COVID-19 infections.
EU agency authorizes Moderna's COVID-19 vaccine
The European Union's medicines agency gave the green light to the Moderna COVID-19 vaccine on Wednesday.
21 Dec 2020
IndiaCoronavirus: Myths about the COVID-19 vaccine busted
As vaccines for COVID-19 have started being rolled out in parts of the world, certain myths have been propagated questioning their safety and efficacy.
21 Dec 2020
South AfricaCoronavirus mutation: Here's what we know about the new strain
As the vaccine for COVID-19 had just started rolling out, the worrisome news of the coronavirus mutating has started circulating.
18 Dec 2020
Donald TrumpUnited States has approved Moderna's COVID-19 vaccine, says Trump
Moderna's COVID-19 vaccine has been approved in the United States, outgoing President Donald Trump announced ahead of the nation's drug regulator.
18 Dec 2020
PfizerFDA advisors recommend Emergency Use Authorization of Moderna vaccine
The US Food and Drug Administration's advisory panel, comprising external experts, has given an emergency use approval to Moderna's COVID-19 vaccine, making it the second drug after Pfizer to receive such an authorization in less than a week.
17 Dec 2020
Donald TrumpUS angling to secure more of Pfizer's coronavirus vaccine
U.S. officials have said that they are actively negotiating for additional purchases of Pfizer's coronavirus vaccine after they missed the chance to lock in a contract this summer since it was still unclear how well the shots would work.
15 Dec 2020
PfizerModerna vaccine has 'no specific safety concerns,' says US regulator
Moderna's COVID-19 vaccine has been found safe and effective, the United States Food and Drug Administration said in a report on Tuesday.
30 Nov 2020
World Health OrganizationModerna says its COVID-19 vaccine '100% effective' against severe cases
United States pharmaceutical company Moderna on Monday said that it will seek emergency approval for its COVID-19 vaccine in the US and Europe.
24 Nov 2020
Oxford UniversityRussia's Sputnik V at least 91% effective, early data suggests
The Russian vaccine for COVID-19, called Sputnik V, has been found at least 91% effective in the second interim analysis.
18 Nov 2020
PfizerPfizer's COVID-19 vaccine '95% effective'; to seek emergency US authorization
Pharmaceutical giant Pfizer and German drugmaker BioNTech on Wednesday said their COVID-19 vaccine has been found 95% effective in final trials.
11 Nov 2020
PfizerUS planning Pfizer's coronavirus vaccine distribution as early as December
The United States could begin inoculating its citizens with Pfizer's coronavirus vaccine as early as December, provided the drugmaker submits data from its trial to health regulators, Health Secretary Alex Azar said on Tuesday.
28 Oct 2020
Donald TrumpCoronavirus vaccine in 2020? US drugmaker Pfizer isn't saying no!
Even as experts worldwide have said that an effective coronavirus vaccine won't be out before 2021, American pharma giant Pfizer is hoping to deliver one this year itself, igniting hopes globally.
13 Oct 2020
Johnson & JohnsonBig setback: Johnson & Johnson pauses coronavirus vaccine trial
Pharma giant Johnson & Johnson, which lagged behind its competitors in the coronavirus vaccine race, paused late-stage trials after a volunteer fell sick.
06 Sep 2020
PfizerCOVID-19 vaccine developers to pledge against rolling out shots prematurely
In light of the havoc wreaked by COVID-19, governments around the world have become more than willing to fast-track regulatory approvals and launch promising vaccines, anti-virals, and tests for their citizens.
04 Sep 2020
Pfizer#VaccineTracker: Early COVID-19 vaccine results expected by September 15
As the COVID-19 crisis is deteriorating with every passing day, all the hopes are pinned on the development of a safe and effective vaccine.
30 Jul 2020
VaccineCoronavirus: How much would the vaccines cost?
As the coronavirus pandemic continues to surge, all hopes rest on the development of a vaccine to beat the virus.
27 Jul 2020
United States of AmericaModerna's COVID-19 vaccine goes into final human trial stage
In a major development, the COVID-19 vaccine developed by biotech giant Moderna Therapeutics has gone into the third and final stage of clinical human trials.
22 Jul 2020
PfizerAs coronavirus pandemic surges, some vaccine makers expect to profit
Some vaccine makers expect to make profits from their coronavirus vaccines, even as the pandemic continues to rage on.
15 Jul 2020
South CarolinaModerna's COVID-19 vaccine: Final trials to begin on July 27
Moderna Therapeutics has come a long way with its candidate vaccine to prevent COVID-19, the novel coronavirus disease.
12 Jun 2020
VaccineModerna's COVID-19 vaccine to go into final-stage trials in July
Moderna Therapeutics has announced that its COVID-19 vaccine is set to go into the third and final stage of clinical human trials.
11 Jun 2020
Johnson & JohnsonJ&J to begin human trials of COVID-19 vaccine in July
American pharma giant Johnson & Johnson has announced that it will be starting human trials of its experimental COVID-19 vaccine sooner than previously planned.
09 Jun 2020
COVID-19Moderna's COVID-19 vaccine: When will it be available?
In the race to develop a vaccine for COVID-19, Moderna Therapeutics is seen as one of the fastest-moving players.
22 May 2020
CoronavirusWhy the vaccine for COVID-19 is still several months away
In a matter of months, a never-seen-before coronavirus originating from China has turned the whole world upside down.
18 May 2020
United States of AmericaModerna's COVID-19 vaccine shows 'positive' results in human trials
Moderna Therapeutics, one of the select few companies working on a COVID-19 vaccine, has revealed positive results from early-stage trials of its formula.
08 May 2020
Oxford UniversityModerna's COVID-19 vaccine gets FDA nod for phase 2 trial
Moderna Therapeutics, one of the select few companies trialing a COVID-19 vaccine, has received US Food and Drug Administration's approval to move into the second phase of the tests.
